Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast-Induced Nephropathy: A Failure of Academic Clinical Science.
Sandilands EA, Rees JMB, Raja K, Dhaun N, Morrison EE, Hickson K, Wraight J, Gray T, Briody L, Cameron S, Thompson AP, Johnston NR, Uren N, Goddard J, Treweeke A, Rushworth G, Webb DJ, Bateman DN, Norrie J, Megson IL, Eddleston M. Sandilands EA, et al. Among authors: johnston nr. Clin Pharmacol Ther. 2022 Jun;111(6):1222-1238. doi: 10.1002/cpt.2541. Epub 2022 Feb 23. Clin Pharmacol Ther. 2022. PMID: 35098531 Free PMC article. Clinical Trial.
Mechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol.
Sandilands EA, Cameron S, Paterson F, Donaldson S, Briody L, Crowe J, Donnelly J, Thompson A, Johnston NR, Mackenzie I, Uren N, Goddard J, Webb DJ, Megson IL, Bateman N, Eddleston M. Sandilands EA, et al. Among authors: johnston nr. BMC Clin Pharmacol. 2012 Feb 3;12:3. doi: 10.1186/1472-6904-12-3. BMC Clin Pharmacol. 2012. PMID: 22305183 Free PMC article. Clinical Trial.
Histamine-induced vasodilatation in the human forearm vasculature.
Sandilands EA, Crowe J, Cuthbert H, Jenkins PJ, Johnston NR, Eddleston M, Bateman DN, Webb DJ. Sandilands EA, et al. Among authors: johnston nr. Br J Clin Pharmacol. 2013 Nov;76(5):699-707. doi: 10.1111/bcp.12110. Br J Clin Pharmacol. 2013. PMID: 23488545 Free PMC article. Clinical Trial.
Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Rankin AJ, Webb DJ. Goddard J, et al. Among authors: johnston nr. Circulation. 2004 Mar 9;109(9):1186-93. doi: 10.1161/01.CIR.0000118499.69469.51. Epub 2004 Feb 23. Circulation. 2004. PMID: 14981006 Clinical Trial.
Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD.
Dhaun N, Melville V, Blackwell S, Talwar DK, Johnston NR, Goddard J, Webb DJ. Dhaun N, et al. Among authors: johnston nr. J Am Soc Nephrol. 2013 Jan;24(1):31-6. doi: 10.1681/ASN.2012040355. Epub 2012 Dec 14. J Am Soc Nephrol. 2013. PMID: 23243212 Free PMC article. Clinical Trial.
61 results